Interestingly, consideration of immune cells PD‐L1 expression can influence the predictive value of PD‐L1 expression as an efficacy biomarker in certain cancers [59], which reflects the complexity of both the tumor microenvironment and the drug mechanism of action (Figure 1). The gene discussed is CD274; the disease is cancer.